Found: 21
Select item for more details and to access through your institution.
A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapy.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1614, doi. 10.1007/s00259-017-3737-x
- By:
- Publication type:
- Article
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1622, doi. 10.1007/s00259-017-3725-1
- By:
- Publication type:
- Article
Effects of arm truncation on the appearance of the halo artifact in Ga-PSMA-11 (HBED-CC) PET/MRI.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1636, doi. 10.1007/s00259-017-3718-0
- By:
- Publication type:
- Article
Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1647, doi. 10.1007/s00259-017-3743-z
- By:
- Publication type:
- Article
Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning after Ga-PSMA-PET imaging.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1656, doi. 10.1007/s00259-017-3746-9
- By:
- Publication type:
- Article
Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1663, doi. 10.1007/s00259-017-3751-z
- By:
- Publication type:
- Article
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1671, doi. 10.1007/s00259-017-3756-7
- By:
- Publication type:
- Article
Players of 'hypoxia orchestra' - what is the role of FMISO?
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Monitoring early response to chemoradiotherapy with F-FMISO dynamic PET in head and neck cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1682, doi. 10.1007/s00259-017-3720-6
- By:
- Publication type:
- Article
SPECT/CT and PET/CT molecular imaging in medullary thyroid carcinoma. Are we running in the right direction?
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Ga-DOTATATE PET/CT in recurrent medullary thyroid carcinoma: a lesion-by-lesion comparison with In-octreotide SPECT/CT and conventional imaging.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1695, doi. 10.1007/s00259-017-3701-9
- By:
- Publication type:
- Article
Clinical impact of PET/CT imaging after adjuvant therapy in patients with oral cavity squamous cell carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1702, doi. 10.1007/s00259-017-3713-5
- By:
- Publication type:
- Article
The role of F-FDG PET/CT in the detection of osteosarcoma recurrence.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1712, doi. 10.1007/s00259-017-3698-0
- By:
- Publication type:
- Article
[18]Fluorodeoxyglucose Positron Emission Tomography for the Textural Features of Cervical Cancer Associated with Lymph Node Metastasis and Histological Type.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1721, doi. 10.1007/s00259-017-3697-1
- By:
- Publication type:
- Article
The value of [C]-acetate PET and [F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1732, doi. 10.1007/s00259-017-3724-2
- By:
- Publication type:
- Article
Imaging children suffering from lymphoma: an evaluation of different F-FDG PET/MRI protocols compared to whole-body DW-MRI.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1742, doi. 10.1007/s00259-017-3726-0
- By:
- Publication type:
- Article
PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1751, doi. 10.1007/s00259-017-3700-x
- By:
- Publication type:
- Article
Reply to: Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging.
- Published in:
- 2017
- By:
- Publication type:
- Letter
F-18 FDG and F-18 Tau PET in posterior cortical atrophy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1779, doi. 10.1007/s00259-017-3738-9
- By:
- Publication type:
- Article
Erratum to: Diagnostic performance of Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.
- Published in:
- 2017
- By:
- Publication type:
- Erratum